DB15069InvestigationalGene Therapies
Pexastimogene devacirepvec is under investigation in clinical trial NCT00429312 (A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma).
- Mechanism
- Curator reviewed
Pharmacologically active on Granulocyte-macrophage colony-stimulating factor
- Also known as
- Pexa-Vec
- Code names
- JX-594
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Pexastimogene devacirepvec, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account